Kathryn L. Terry, ScD

Publications

• Amankwah EK, Kelemen LE, Wang Q, Song H, Chenevix-Trench G, Beesley J, Webb PM, Pearce CL, Wu AH, Pike MC, Stram DO, Chang-Claude J, Wang-Gohrke S, Ness RB, Goode EL, Cunningham JM, Fridley BL, Vierkant RA, Tworoger SS, Whittemore AS, McGuire V, Sieh W, G
  21415361
• Michels KB, Terry KL, Eliassen AH, Hankinson SE, Willett WC.Adult weight change and incidence of premenopausal breast cancer.Int J Cancer. 2011 Mar 16.
  21413008
• Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver HA, Antonenkova N, Antoniou AC, Bcfr Investigators SG, Beattie MS, Beckmann M, Birrer MJ, Bogdanova N, Bolton KL, Brewster W, Brooks-Wilson A, Brown R, Bützow R, Caldes T, Caligo MA
  21385923
• Harris HR, Willett WC, Terry KL, Michels KB.Body fat distribution and risk of premenopausal breast cancer in the Nurses' Health Study II.Journal of the National Cancer Institute. 2011 Feb 2;103(3):273-8.
  21163903
• Near AM, Wu AH, Templeman C, Van Den Berg DJ, Doherty JA, Rossing MA, Goode EL, Cunningham JM, Vierkant RA, Fridley BL, Chenevix-Trench G, Webb PM, , , Kjær SK, Hogdall E, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Schildkraut JM, Moorman PG, Pal
  20719308
• Cramer DW, Vitonis AF, Welch WR, Terry KL, Goodman A, Rueda BR, Berkowitz RS.Correlates of the preoperative level of CA125 at presentation of ovarian cancer.Gynecol Oncol. 2010 Dec;119(3):462-8.
  20850174
• Terry KL, Tworoger SS, Goode EL, Gates MA, Titus-Ernstoff L, Kelemen LE, Sellers TA, Hankinson SE, Cramer DW.MTHFR polymorphisms in relation to ovarian cancer risk.Gynecol Oncol. 2010 Nov;119(2):319-24.
  20817226
• Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, Wu AH, Brewster W, Anton-Culver H, Ziogas A, Narod SA, Levine DA, Kaye SB, Brown R, Paul J,
  20852633
• Lurie G, Terry KL, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Palmieri RT, Cramer DW, Goodman MT.Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk.Cancer Causes Control. 2010 Oct;21(10
  20559705
• Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, deFazio A, Gava N, Webb PM, Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ, Wilkens LR, Ness RB, Moysich KB, Chang-Claude J, Wang-Gohrke S, Cramer DW, Terry KL, Hankinson SE, Two
  20628624
• Phelan CM, Tsai YY, Goode EL, Vierkant RA, Fridley BL, Beesley J, Chen XQ, Webb PM, Chanock S, Cramer DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, Wang-Gohrke S, Hein R, Green AC, Lissowska J, Carney ME, Lurie G, Wilkens LR, Ness RB
  20142253
• Titus-Ernstoff L, Rees JR, Terry KL, Cramer DW.Breast-feeding the last born child and risk of ovarian cancer.Cancer Causes Control. 2010 Feb;21(2):201-7.
  19902367
• Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Hogdall E, Kjaer SK, Hogdall C, Good
  20056644
• Terry KL, Tworoger SS, Gates MA, Cramer DW, Hankinson SE.Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.Carcinogenesis. 2009 Dec;30(12):2042-6.
  19858071
• Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R, Dörk T, Goode EL, Goodman MT, Schildkraut JM, Sellers T, Baglietto L, Beckmann MW, Beesley J, Blaakaer J, Carney ME, Chanock S, Che
  19648919
• Schildkraut JM,Goode EL,Clyde MA,Iversen ES,Moorman PG,Berchuck A,Marks JR,Lissowska J,Brinton L,Peplonska B,Cunningham JM,Vierkant RA,Rider DN,Chenevix-Trench G,Webb PM,Beesley J,Chen X,Phelan C,Sutphen R,Sellers TA,Pearce L,Wu AH,Van Den Berg D,Conti D,
  19276375
• Gates MA,Tworoger SS,Terry KL,De Vivo I,Hunter DJ,Hankinson SE,Cramer DW.Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations.Int J Cancer. 2009 Feb 1;124(3):729-33.
  18973230
• Kotsopoulos J,Vitonis AF,Terry KL,De Vivo I,Cramer DW,Hankinson SE,Tworoger SS.Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer.Cancer Causes Control. 2009 Apr;20(3):335-44.
  18941913
• Gates MA,Tworoger SS,Terry KL,Titus-Ernstoff L,Rosner B,De Vivo I,Cramer DW,Hankinson SE.Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer.Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2436-44.
  18768514
• Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Dicioccio RA, McGuire V, Whittemore AS, Song H, Easton DF, Pharoah PD, Garcia-Closas M, Chanock S, Lissowska J, Brinton L, Terry KL, Cra
  18431743
• Terry K, McGrath M, Lee IM, Buring J, De Vivo I.MDM2 SNP309 Is Associated with Endometrial Cancer Risk.Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):983-6.
  18398041
• Pearce CL, Wu AH, Gayther SA, Bale AE, Beck PA, Beesley J, Chanock S, Cramer DW, DiCioccio R, Edwards R, Fredericksen ZS, Garcia-Closas M, Goode EL, Green AC, Hartmann LC, Hogdall E, Kjaer SK, Lissowska J, McGuire V, Modugno F, Moysich K, Ness RB, Ramus S
  18219286
• Terry KL, Missmer SA, Hankinson SE, Willett WC, De Vivo I.Lycopene and other carotenoid intake in relation to risk of uterine leiomyomata.Am J Obstet Gynecol. 2008 Jan;198(1):37.e1-8.
  17981250
• Terry KL, De Vivo I, Hankinson SE, Spiegelman D, Wise LA, Missmer SA.Anthropometric characteristics and risk of uterine leiomyoma.Epidemiology. 2007 Nov;18(6):758-63.
  17917603
• Terry KL, Titus-Ernstoff L, McKolanis JR, Welch WR, Finn OJ, Cramer DW.Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):30-5.
  17220329
• Terry KL, Willett WC, Rich-Edwards JW, Michels KB.A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer.Arch Intern Med. 2006 Dec 11-25;166(22):2484-9.
  17159014
• Michels KB, Terry KL, Willett WC.Longitudinal study on the role of body size in premenopausal breast cancer.Arch Intern Med. 2006 Nov 27;166(21):2395-402.
  17130395
• Michels KB, Xue F, Terry KL, Willett WC.Longitudinal study of birthweight and the incidence of breast cancer in adulthood.Carcinogenesis. 2006 Dec;27(12):2464-8.
  16777984
• Kusano AS, Trichopoulos D, Terry KL, Chen WY, Willett WC, Michels KB.A prospective study of breast size and premenopausal breast cancer incidence.Int J Cancer. 2006 Apr 15;118(8):2031-4.
  16284954
• Terry KL, De Vivo I, Titus-Ernstoff L, Shih MC, Cramer DW.Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk.Cancer Res. 2005 Jul 1;65(13):5974-81.
  15994977
• Terry KL, Willett WC, Rich-Edwards JW, Hunter DJ, Michels KB.Menstrual cycle characteristics and incidence of premenopausal breast cancer.Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1509-13.
  15941964
• Terry KL, De Vivo I, Titus-Ernstoff L, Sluss PM, Cramer DW.Genetic variation in the progesterone receptor gene and ovarian cancer risk.Am J Epidemiol. 2005 Mar 1;161(5):442-51.
  15718480
• Terry KL, Sluss PM, Skates SJ, Mok SC, Ye B, Vitonis AF, Cramer DW.Blood and urine markers for ovarian cancer: a comprehensive review.Dis Markers. 2004;20(2):53-70.
  15322314
• Terry KL, Titus-Ernstoff L, Garner EO, Vitonis AF, Cramer DW.Interaction between CYP1A1 polymorphic variants and dietary exposures influencing ovarian cancer risk.Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):187-90.
  12646505
• Morris MJ, Tong WP, Cordon-Cardo C, Drobnjak M, Kelly WK, Slovin SF, Terry KL, Siedlecki K, Swanson P, Rafi M, DiPaola RS, Rosen N, Scher HI.Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patien
  11895895